← All trials
NCT02643303
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 28, 2016
- Primary completion
- Aug 1, 2022
- Completion date
- Aug 1, 2022
- First posted
- —
- Last posted
- —
- Enrollment
- 102
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- Ludwig Institute for Cancer ResearchLead sponsor
- Cancer Research InstituteCollaborator
- University of VirginiaStudy chair
- MedImmuneCollaborator
- Icahn School of Medicine at Mount SinaiStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.